Marcos Ferreira | BrazMedChem 2022 | Galoá Proceedings

Aché Laboratórios Farmacêuticos S.A.

Marcos Ferreira

Is this your profile? Do login to access your certificates

Identification of novel chemical starting points for the development of LMTK3 kinase inhibitors
Vitor Medeiros Almeida ¹
Marcos Ferreira ²
Mariana Damiao ²
Jéssica E. Takarada ¹
Bruno Teodoro ²
Micael Rodrigues Cunha ³
Alessandra Mascarello ²
Rafael M. Couñago ¹
Hatylas F. Zaneti de Azevedo ²
¹ Centro de Química Medicinal (CQMED), Universidade Estadual de Campinas (UNICAMP)
² Aché Laboratórios Farmacêuticos S.A.
³ Universidade Estadual de Campinas
Vol 2, 2022 -
153235

1. Strategies in Drug Design

Poster

Co-authors (8)

Publications in other proceedings

BrazMedChem 2019
Discovering drug repurposing opportunities for the treatment of Chagas disease using ligand-based machine learning methods